[go: up one dir, main page]

IL155334A0 - Novel anticholinergic agents that can be used as medicaments and method for the production thereof - Google Patents

Novel anticholinergic agents that can be used as medicaments and method for the production thereof

Info

Publication number
IL155334A0
IL155334A0 IL15533401A IL15533401A IL155334A0 IL 155334 A0 IL155334 A0 IL 155334A0 IL 15533401 A IL15533401 A IL 15533401A IL 15533401 A IL15533401 A IL 15533401A IL 155334 A0 IL155334 A0 IL 155334A0
Authority
IL
Israel
Prior art keywords
medicaments
production
anticholinergic agents
novel anticholinergic
novel
Prior art date
Application number
IL15533401A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of IL155334A0 publication Critical patent/IL155334A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
IL15533401A 2000-10-14 2001-09-28 Novel anticholinergic agents that can be used as medicaments and method for the production thereof IL155334A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10050994A DE10050994A1 (de) 2000-10-14 2000-10-14 Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
PCT/EP2001/011226 WO2002032899A1 (de) 2000-10-14 2001-09-28 Neue als arzneimittel einsetzbare anticholinergika sowie verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
IL155334A0 true IL155334A0 (en) 2003-11-23

Family

ID=7659808

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15533401A IL155334A0 (en) 2000-10-14 2001-09-28 Novel anticholinergic agents that can be used as medicaments and method for the production thereof
IL155334A IL155334A (en) 2000-10-14 2003-04-10 Anticholinergic scopine and tropenol compounds, method for their production and pharmaceutical compositions comprising them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL155334A IL155334A (en) 2000-10-14 2003-04-10 Anticholinergic scopine and tropenol compounds, method for their production and pharmaceutical compositions comprising them

Country Status (37)

Country Link
EP (2) EP1382606A3 (et)
JP (2) JP4109106B2 (et)
KR (1) KR100830359B1 (et)
CN (1) CN1275962C (et)
AR (1) AR035589A1 (et)
AT (1) ATE259805T1 (et)
AU (2) AU1397502A (et)
BG (1) BG66225B1 (et)
BR (1) BR0114635A (et)
CA (1) CA2425557C (et)
DE (2) DE10050994A1 (et)
DK (1) DK1325001T3 (et)
EA (1) EA005816B1 (et)
EC (1) ECSP034542A (et)
EE (1) EE05179B1 (et)
ES (1) ES2215147T3 (et)
HR (1) HRP20030278B1 (et)
HU (1) HUP0301203A3 (et)
IL (2) IL155334A0 (et)
ME (1) MEP39908A (et)
MX (1) MXPA03003160A (et)
MY (1) MY127144A (et)
NO (1) NO328207B1 (et)
NZ (1) NZ525836A (et)
PE (1) PE20020433A1 (et)
PL (1) PL207311B1 (et)
PT (1) PT1325001E (et)
RS (1) RS50464B (et)
SA (1) SA01220414B1 (et)
SI (1) SI1325001T1 (et)
SK (1) SK287138B6 (et)
TR (1) TR200400376T4 (et)
TW (1) TWI306098B (et)
UA (1) UA73804C2 (et)
UY (1) UY26958A1 (et)
WO (1) WO2002032899A1 (et)
ZA (1) ZA200302914B (et)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US7405224B2 (en) 2002-01-31 2008-07-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
DE10203753A1 (de) * 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10216429A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
US7417051B2 (en) 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
DE10256317A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Arzneimittel enthaltend Betamimetika und ein neues Anticholinergikum
CA2481468C (en) * 2002-04-12 2011-02-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments containing betamimetic drugs and a novel anticholinesterase drug
US7084153B2 (en) 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
DE10224091A1 (de) * 2002-05-31 2003-12-11 Boehringer Ingelheim Pharma Technisches Verfahren zur Herstellung von Tropenol
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
DE10230751A1 (de) 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
AU2003245989A1 (en) 2002-07-09 2004-01-23 Boehringer Ingelheim Pharma Gmbh And Co. Kg Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
DE10230750A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten
EP1908468A1 (de) * 2002-08-14 2008-04-09 Boehringer Ingelheim Pharma GmbH & Co. KG Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (de) * 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
DE10323966A1 (de) * 2003-05-27 2004-12-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
US7332175B2 (en) 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
US7462367B2 (en) 2003-07-11 2008-12-09 Boehringer Ingelheim International Gmbh Anticholinergic powder formulations for inhalation
DE10331350A1 (de) * 2003-07-11 2005-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation enthaltend ein neues Anticholinergikum
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
JP2007500146A (ja) * 2003-07-28 2007-01-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベータ受容体刺激薬及び抗コリン作用薬を含有する吸入用医薬品
WO2005013967A1 (en) * 2003-07-28 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders
ATE435018T1 (de) * 2003-07-28 2009-07-15 Boehringer Ingelheim Int Medikamente zur inhalation mit steroiden und einem neuen fluorencarbonsäureester
WO2005014044A1 (en) * 2003-07-29 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising betamimetics and an anticholinergic
ATE526967T1 (de) * 2003-07-31 2011-10-15 Boehringer Ingelheim Int Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum
EP1504756A1 (en) * 2003-08-06 2005-02-09 Kyowa Hakko Kogyo Co., Ltd Medicament compositions comprising a heterocyclic compound and an anticholinergic
DE10345065A1 (de) 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
EP1706118A1 (en) * 2004-01-09 2006-10-04 Boehringer Ingelheim International GmbH New pharmaceutical compositions based on a scopineester and nicotinamide derivatives
US7507745B2 (en) 2004-02-20 2009-03-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
US20050186175A1 (en) * 2004-02-20 2005-08-25 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins
EP1718301A1 (en) * 2004-02-20 2006-11-08 Boehringer Ingelheim International GmbH Pharmaceutical compositions based on anticholinergics and pegsunercept
DE102004016179A1 (de) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von proliferativen Prozessen
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE602004020337D1 (de) * 2004-08-11 2009-05-14 Boehringer Ingelheim Pharma Anticholinergika enthaltende Arzneimittel zur Behandlung von Krankheiten der ableitenden Harnwege
DE102004056578A1 (de) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Formoterol und ein Steroid
CA2597942A1 (en) * 2005-02-16 2006-08-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising anticholinergics and etiprednol
EP1858554A2 (en) * 2005-03-09 2007-11-28 Boehringer Ingelheim International GmbH New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
EP1893203A2 (en) * 2005-05-31 2008-03-05 Boehringer Ingelheim International GmbH Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
CA2611907A1 (en) * 2005-06-17 2006-12-21 Boehringer Ingelheim International Gmbh Mrp iv inhibitors for the treatment of respiratory diseases
DE102005030733A1 (de) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
WO2007020227A1 (de) 2005-08-15 2007-02-22 Boehringer Ingelheim International Gmbh Verfahren zur herstellung von betamimetika
EP1948164A1 (en) 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Pharmaceutical compositions of muscarinic receptor antagonists
DE102005055957A1 (de) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055961A1 (de) * 2005-11-24 2007-05-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055963A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE502007006951D1 (de) 2006-08-07 2011-05-26 Boehringer Ingelheim Pharma Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
HRP20120361T1 (hr) 2007-03-14 2012-05-31 Ranbaxy Laboratories Limited DERIVATI PIRAZOLO[3,4-b]PIRIDINA KAO INHIBITORI FOSFODIESTERAZE
EP2011538B1 (en) 2007-07-06 2016-02-17 Vectura Delivery Devices Limited Inhaler
US20100234411A1 (en) * 2007-07-18 2010-09-16 Boehringer Ingelheim Intermational Gmbh New Combination for the Treatment of Respiratory Diseases
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2082768A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082766A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Blister Strip Coil Forming
EP2082767A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082771A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082772A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP2432531B1 (de) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
NZ599295A (en) 2009-11-25 2014-06-27 Boehringer Ingelheim Int Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
NZ706573A (en) 2012-12-21 2019-11-29 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
LT2934544T (lt) 2012-12-21 2019-02-25 Boehringer Ingelheim Vetmedica Gmbh Farmacinė kompozicija, apimanti ciklezonidą
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
BR112016023932B1 (pt) 2014-05-07 2022-11-29 Boehringer Ingelheim International Gmbh Nebulizador
DK3139984T3 (da) 2014-05-07 2021-07-19 Boehringer Ingelheim Int Forstøver
EP3139979B1 (en) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unit, nebulizer and method
KR102618119B1 (ko) 2014-06-18 2023-12-27 베링거잉겔하임베트메디카게엠베하 말의 기도 질환의 치료를 위한 무스카린 길항제 및 이의 병용물
WO2017040764A1 (en) * 2015-09-04 2017-03-09 Janssen Pharmaceutica Nv Therapeutic compounds for pain and synthesis thereof
CN113292574B (zh) * 2020-02-21 2022-05-03 四川大学 一类手性多环的托品烷化合物及其制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
BG107688A (bg) 2003-09-30
EA005816B1 (ru) 2005-06-30
IL155334A (en) 2009-02-11
MY127144A (en) 2006-11-30
SA01220414B1 (ar) 2007-01-20
EE200300151A (et) 2003-06-16
CA2425557A1 (en) 2003-04-11
CA2425557C (en) 2007-11-13
CN1468236A (zh) 2004-01-14
TR200400376T4 (tr) 2004-03-22
EP1325001A1 (de) 2003-07-09
DE50101524D1 (de) 2004-03-25
SK287138B6 (sk) 2010-01-07
AR035589A1 (es) 2004-06-16
NZ525836A (en) 2004-09-24
DE10050994A1 (de) 2002-04-18
WO2002032899A1 (de) 2002-04-25
SI1325001T1 (sl) 2004-08-31
HRP20030278A2 (en) 2005-02-28
AU1397502A (en) 2002-04-29
CN1275962C (zh) 2006-09-20
ZA200302914B (en) 2003-11-14
BR0114635A (pt) 2004-02-10
MEP39908A (en) 2011-02-10
TWI306098B (en) 2009-02-11
UY26958A1 (es) 2002-06-20
ATE259805T1 (de) 2004-03-15
EE05179B1 (et) 2009-06-15
ES2215147T3 (es) 2004-10-01
BG66225B1 (bg) 2012-06-29
HUP0301203A3 (en) 2006-05-29
HK1060566A1 (en) 2004-08-13
EP1382606A2 (de) 2004-01-21
EP1325001B1 (de) 2004-02-18
PL207311B1 (pl) 2010-11-30
AU2002213975B2 (en) 2006-11-09
JP4109106B2 (ja) 2008-07-02
UA73804C2 (en) 2005-09-15
KR100830359B1 (ko) 2008-05-20
RS50464B (sr) 2010-03-02
YU29503A (sh) 2006-03-03
PE20020433A1 (es) 2002-06-28
NO20031693D0 (no) 2003-04-11
JP2008120834A (ja) 2008-05-29
KR20030041165A (ko) 2003-05-23
NO20031693L (no) 2003-05-28
HRP20030278B1 (en) 2006-02-28
MXPA03003160A (es) 2005-09-09
DK1325001T3 (da) 2004-06-21
NO328207B1 (no) 2010-01-11
EA200300459A1 (ru) 2003-10-30
SK4352003A3 (en) 2003-08-05
EP1382606A3 (de) 2004-10-13
JP2004511557A (ja) 2004-04-15
ECSP034542A (es) 2003-06-25
PL360673A1 (en) 2004-09-20
HUP0301203A2 (hu) 2003-10-28
PT1325001E (pt) 2004-07-30

Similar Documents

Publication Publication Date Title
AU1397502A (en) Novel anticholinergic agents that can be used as medicaments and method for the production thereof
AU2002213975A1 (en) Novel anticholinergic agents that can be used as medicaments and method for the production thereof
HUP0400333A3 (en) Crystalline anticholinergic, method for its production, and use thereof in the production of pharmaceutical composition
AU2002213977A1 (en) Novel anticholinergics, method for the production thereof and use thereof as medicaments
PL369889A1 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
PL351687A1 (en) Polyolefins and method for the production thereof
HUP0401081A3 (en) Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and their use
HUP0203875A3 (en) Microcapsule and process for production thereof
AU2003206760A1 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
GB2381537B (en) High-cleanliness steel and process for producing the same
IL161893A0 (en) 5-Phenylpyrimidines, agents comprising the same, method for production and use thereof
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
IL153505A0 (en) Dds compound and process for the preparation thereof
HUP0301211A3 (en) Haemostatically active preparation containing vwf and method for the production thereof
PL345619A1 (en) Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments
PL351616A1 (en) Polyolefin compositions, method for the production and use thereof
HUP0200928A3 (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
AU2001295579A1 (en) Pants and method for the production thereof
HUP0105345A3 (en) Amlodipine bezylate tablets having extended stability and process for producing the same
AU6222901A (en) Cyclipostins, a method for their production and the use of the same
AU7400401A (en) Method for the production of 2- coumarone and substituted 2-coumarones
GB2410503B (en) High-cleanliness steel and process for producing the same
EP1299396A4 (en) NOVEL CEPHALOSPORIN COMPOUNDS AND PROCESSES FOR THE PREPARATION THEREOF
HUP0203463A3 (en) Bis(1-aziridino-1-hydroxyiminomethyl)-derivatives, method for the production thereof and use thereof as anti-tumoral agents
EP1338275A4 (en) Pharmaceutical composition, its use and method of making the same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed